Article info

Download PDFPDF
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis

Authors

  • Tate M Johnson Medicine & Research Service, VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USADepartment of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA PubMed articlesGoogle scholar articles
  • Harlan R Sayles Medicine & Research Service, VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USADepartment of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA PubMed articlesGoogle scholar articles
  • Joshua F Baker Department of Medicine, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USARheumatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Michael D George Department of Medicine, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USARheumatology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Punyasha Roul Medicine & Research Service, VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA PubMed articlesGoogle scholar articles
  • Cheng Zheng Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, USA PubMed articlesGoogle scholar articles
  • Brian Sauer Rheumatology, VA Salt Lake City Health Care System, Salt Lake City, Utah, USADepartment of Medicine, Division of Rheumatology, University of Utah Medical Center, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles
  • Katherine P Liao Rheumatology, VA Boston Healthcare System, West Roxbury, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Daniel R Anderson Department of Internal Medicine, Division of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska, USA PubMed articlesGoogle scholar articles
  • Ted R Mikuls Medicine & Research Service, VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USADepartment of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA PubMed articlesGoogle scholar articles
  • Bryant R England Medicine & Research Service, VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USADepartment of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bryant R England, Medicine & Research Service, VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA; bryant.england{at}unmc.edu
View Full Text

Citation

Johnson TM, Sayles HR, Baker JF, et al
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis

Publication history

  • Received February 8, 2021
  • Accepted May 19, 2021
  • First published May 28, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.